const e=()=>[{title:"üß† Cerebral Palsy Prevention and Care (CPAC) - Comprehensive Obstetric Protocol",subsections:[{title:"üéØ CPAC Framework - Definition and Scope",points:["üß† **Definition**: CPAC (Cerebral Palsy Prevention and Care) is a comprehensive clinical framework focusing on prevention, early identification, and management of factors leading to cerebral palsy during pregnancy, labor, and neonatal period","üìä **Epidemiology**: Cerebral palsy affects 2-3 per 1000 live births globally, with 70-80% of cases having prenatal or perinatal origins","üéØ **Prevention Focus**: Primary (risk factor modification), Secondary (early intervention), Tertiary (optimal care management)","‚ö° **Risk Factors**: Prematurity (major factor), intrauterine infections, hypoxic-ischemic events, genetic factors, maternal conditions","üî¨ **Evidence Base**: Level A evidence for intrapartum monitoring, magnesium sulfate neuroprotection, hypothermia therapy","üåç **Global Impact**: Leading cause of childhood disability, significant burden on families and healthcare systems","üí∞ **Economic Burden**: Lifetime costs >$1 million per affected child, emphasizing prevention importance","üìö **Guidelines**: WHO, AAP, ACOG, RCOG recommendations for cerebral palsy prevention strategies"]},{title:"üî¨ Pathophysiology and Risk Assessment",points:["üß¨ **Pathophysiologic Mechanisms**:","‚Ä¢ **Hypoxic-Ischemic Injury**: Perinatal asphyxia, placental insufficiency, cord accidents","‚Ä¢ **Inflammatory Pathways**: Chorioamnionitis, maternal infections, cytokine release","‚Ä¢ **Vascular Disruption**: Stroke, hemorrhage, periventricular leukomalacia","‚Ä¢ **Genetic Factors**: Single gene disorders, chromosomal abnormalities, metabolic disorders","","‚ö° **High-Risk Pregnancy Identification**:","‚Ä¢ **Maternal Factors**: Advanced age (>35), multiple gestation, previous CP child","‚Ä¢ **Medical Conditions**: Diabetes, hypertension, thyroid disease, epilepsy","‚Ä¢ **Obstetric History**: Previous stillbirth, growth restriction, preterm delivery","‚Ä¢ **Current Pregnancy**: IUGR, oligohydramnios, placental abnormalities","","üîç **Risk Stratification Tools**:","‚Ä¢ **Scoring Systems**: Validated risk assessment algorithms","‚Ä¢ **Biomarkers**: Inflammatory markers, genetic testing, metabolic screening","‚Ä¢ **Imaging**: Fetal MRI, neurosonography, placental assessment","‚Ä¢ **Monitoring**: Continuous fetal surveillance, Doppler studies","","üìä **Evidence-Based Risk Factors (Relative Risk)**:","‚Ä¢ Preterm birth <32 weeks: RR 40-100x","‚Ä¢ Birth weight <1500g: RR 25-50x","‚Ä¢ Chorioamnionitis: RR 2-5x","‚Ä¢ Multiple gestation: RR 2-8x"]},{title:"üõ°Ô∏è Prevention Strategies - Primary Prevention",points:["üíä **Pharmacological Interventions**:","‚Ä¢ **Magnesium Sulfate**: Neuroprotection for preterm delivery <32 weeks, 4-6g loading dose","‚Ä¢ **Antenatal Corticosteroids**: Betamethasone 12mg x2 doses, lung and brain maturation","‚Ä¢ **Progesterone**: Prevention of preterm birth in high-risk pregnancies","‚Ä¢ **Aspirin**: Low-dose for preeclampsia prevention in high-risk women","","ü¶† **Infection Prevention**:","‚Ä¢ **GBS Screening**: Universal screening 35-37 weeks, intrapartum antibiotics","‚Ä¢ **UTI Management**: Screening and treatment, prevent ascending infections","‚Ä¢ **Immunizations**: Influenza, COVID-19, pertussis during pregnancy","‚Ä¢ **Chorioamnionitis Prevention**: Sterile technique, antibiotic prophylaxis","","ü©∫ **Optimal Pregnancy Management**:","‚Ä¢ **Preconception Care**: Folic acid, chronic disease optimization, genetic counseling","‚Ä¢ **Regular Monitoring**: Early and consistent antenatal care, growth surveillance","‚Ä¢ **Nutritional Support**: Adequate protein, iron, essential fatty acids","‚Ä¢ **Lifestyle Modifications**: Smoking cessation, alcohol avoidance, drug rehabilitation","","‚è∞ **Timing Optimization**:","‚Ä¢ **Delivery Planning**: Avoid early term delivery without indication","‚Ä¢ **Mode of Delivery**: Evidence-based cesarean section decisions","‚Ä¢ **Labor Management**: Appropriate monitoring, intervention thresholds","‚Ä¢ **Preterm Prevention**: Cervical length monitoring, cerclage when indicated"]},{title:"üìä Intrapartum Monitoring and Management",points:["üíì **Fetal Heart Rate Monitoring**:","‚Ä¢ **Continuous EFM**: High-risk pregnancies, interpretation standardization","‚Ä¢ **Fetal Scalp Sampling**: When EFM non-reassuring, pH >7.25 normal","‚Ä¢ **ST Analysis (STAN)**: Adjunct to CTG, reduces operative deliveries","‚Ä¢ **Intrauterine Pressure**: Monitor contraction adequacy, detect uterine rupture","","ü©∏ **Cord Blood Management**:","‚Ä¢ **Delayed Cord Clamping**: 30-60 seconds for term, 30-45 seconds preterm","‚Ä¢ **Cord Blood Gas**: Routine for high-risk deliveries, medico-legal documentation","‚Ä¢ **Cord Milking**: Alternative for preterm infants when DCC not feasible","‚Ä¢ **pH Thresholds**: Arterial pH <7.0 significant acidemia, neurologic risk","","‚ö° **Emergency Protocols**:","‚Ä¢ **Category I Cesarean**: Decision-to-delivery <30 minutes for fetal compromise","‚Ä¢ **Shoulder Dystocia**: McRoberts, suprapubic pressure, internal maneuvers","‚Ä¢ **Cord Prolapse**: Immediate cesarean, manual elevation of presenting part","‚Ä¢ **Uterine Rupture**: Emergency laparotomy, fetal extraction, repair","","üîÑ **Team Communication**:","‚Ä¢ **SBAR Handoffs**: Structured communication during shift changes","‚Ä¢ **Multidisciplinary**: Obstetrics, anesthesia, pediatrics, nursing coordination","‚Ä¢ **Documentation**: Real-time charting, incident reporting, outcome tracking","‚Ä¢ **Family Communication**: Regular updates, informed consent, support"]},{title:"üë∂ Neonatal Resuscitation and Early Care",points:["üö® **Immediate Resuscitation Protocol**:","‚Ä¢ **Golden Minute**: Initial assessment and intervention within 60 seconds","‚Ä¢ **Temperature Management**: Warm environment, dry thoroughly, skin-to-skin","‚Ä¢ **Airway Management**: Position, suction if needed, positive pressure ventilation","‚Ä¢ **Circulation Support**: Chest compressions if HR <60 despite ventilation","","üå°Ô∏è **Therapeutic Hypothermia**:","‚Ä¢ **Indications**: Moderate-severe HIE in term/near-term infants","‚Ä¢ **Timing**: Initiate within 6 hours of birth for maximum benefit","‚Ä¢ **Target Temperature**: 33.5¬∞C ¬± 0.5¬∞C for 72 hours","‚Ä¢ **Monitoring**: Continuous EEG, amplitude-integrated EEG, MRI assessment","","üß† **Neurological Assessment**:","‚Ä¢ **Sarnat Staging**: Grade HIE severity, guide treatment decisions","‚Ä¢ **Neurological Examination**: Tone, reflexes, level of consciousness","‚Ä¢ **Imaging**: Cranial ultrasound, MRI for prognostic information","‚Ä¢ **Electrophysiology**: EEG monitoring, evoked potentials","","üíä **Supportive Care**:","‚Ä¢ **Glucose Management**: Maintain euglycemia, prevent hypoglycemia","‚Ä¢ **Fluid Balance**: Careful monitoring, prevent cerebral edema","‚Ä¢ **Seizure Management**: Phenobarbital first-line, EEG monitoring","‚Ä¢ **Nutrition**: Early feeding when appropriate, parenteral if needed"]},{title:"üè• Quality Improvement and Systems Approach",points:["üìä **Quality Metrics and Monitoring**:","‚Ä¢ **Process Indicators**: Magnesium sulfate use rates, steroid administration","‚Ä¢ **Outcome Measures**: Cerebral palsy rates, HIE incidence, mortality","‚Ä¢ **Balancing Measures**: Cesarean rates, maternal morbidity, NICU admissions","‚Ä¢ **Real-time Dashboards**: Continuous monitoring, trend identification","","üéØ **Standardization Initiatives**:","‚Ä¢ **Clinical Protocols**: Evidence-based guidelines, decision algorithms","‚Ä¢ **Training Programs**: Regular simulation, competency assessment","‚Ä¢ **Equipment Standards**: Monitoring devices, resuscitation equipment","‚Ä¢ **Communication Tools**: SBAR, handoff protocols, emergency alerts","","üîç **Audit and Review Processes**:","‚Ä¢ **Case Reviews**: Multidisciplinary analysis of adverse outcomes","‚Ä¢ **Root Cause Analysis**: System-based approach to incident investigation","‚Ä¢ **Benchmarking**: Compare outcomes with national/international standards","‚Ä¢ **Feedback Loops**: Regular staff feedback, continuous improvement cycles","","üìö **Education and Training**:","‚Ä¢ **Simulation-Based**: High-fidelity scenarios, team training","‚Ä¢ **E-learning**: Online modules, competency tracking","‚Ä¢ **Interprofessional**: Obstetrics, pediatrics, anesthesia collaboration","‚Ä¢ **Patient Education**: Risk awareness, prevention strategies"]},{title:"üåç Implementation in Resource-Limited Settings",points:["üí∞ **Cost-Effective Strategies**:","‚Ä¢ **Essential Interventions**: Focus on high-impact, low-cost measures","‚Ä¢ **Local Capacity**: Training local healthcare providers","‚Ä¢ **Technology Adaptation**: Simple, robust monitoring equipment","‚Ä¢ **Community Engagement**: Traditional birth attendant training","","üîß **Appropriate Technology**:","‚Ä¢ **Low-Cost Monitoring**: Doppler devices, manual blood pressure","‚Ä¢ **Mobile Health**: Smartphone apps for risk assessment, education","‚Ä¢ **Telemedicine**: Remote consultation, specialist support","‚Ä¢ **Solar Power**: Sustainable energy for medical equipment","","üìö **Kenya-Specific Implementation**:","‚Ä¢ **MOH Integration**: Align with national maternal health policies","‚Ä¢ **Training Curriculum**: Include in medical, nursing education","‚Ä¢ **Quality Assurance**: Establish monitoring systems, outcome tracking","‚Ä¢ **Cultural Sensitivity**: Adapt protocols to local practices, beliefs","","ü§ù **Partnership Development**:","‚Ä¢ **International Support**: WHO, UNICEF technical assistance","‚Ä¢ **Academic Collaboration**: Research partnerships, knowledge exchange","‚Ä¢ **NGO Partnerships**: Implementation support, community outreach","‚Ä¢ **Private Sector**: Corporate social responsibility, equipment supply"]}]},{title:"üìã Advanced CPAC Protocols and Special Considerations",subsections:[{title:"üî¨ Advanced Risk Assessment and Biomarkers",points:["üß¨ **Genetic Risk Assessment**:","‚Ä¢ **Family History**: Previous CP, genetic syndromes, consanguinity","‚Ä¢ **Genetic Testing**: Chromosomal microarray, exome sequencing","‚Ä¢ **Metabolic Screening**: Inborn errors of metabolism, mitochondrial disorders","‚Ä¢ **Pharmacogenomics**: Drug metabolism variants, personalized therapy","","üî¨ **Inflammatory Biomarkers**:","‚Ä¢ **Cytokines**: IL-1Œ≤, IL-6, TNF-Œ± elevation in maternal blood","‚Ä¢ **C-Reactive Protein**: Maternal CRP >8mg/L associated with CP risk","‚Ä¢ **Procalcitonin**: Early sepsis marker, infection identification","‚Ä¢ **S100B Protein**: Neuronal injury marker, prognostic value","","üß† **Neuroimaging Advances**:","‚Ä¢ **Fetal MRI**: Advanced sequences, tractography, connectivity studies","‚Ä¢ **Ultrasound**: 3D/4D imaging, Doppler studies, elastography","‚Ä¢ **DTI (Diffusion Tensor Imaging)**: White matter integrity assessment","‚Ä¢ **fMRI**: Functional connectivity, brain network development","","‚ö° **Predictive Models**:","‚Ä¢ **Machine Learning**: AI algorithms for risk prediction","‚Ä¢ **Multi-modal Integration**: Clinical, imaging, biochemical data","‚Ä¢ **Risk Calculators**: Real-time probability assessment","‚Ä¢ **Decision Support**: Clinical decision-making tools"]},{title:"üíä Advanced Therapeutic Interventions",points:["üß† **Neuroprotective Agents**:","‚Ä¢ **Magnesium Sulfate**: Optimal dosing protocols, timing considerations","‚Ä¢ **Erythropoietin**: Neuroprotection in HIE, clinical trials ongoing","‚Ä¢ **Melatonin**: Antioxidant properties, maternal/fetal administration","‚Ä¢ **Allopurinol**: Free radical scavenger, potential neuroprotection","","üå°Ô∏è **Advanced Hypothermia Protocols**:","‚Ä¢ **Selective Head Cooling**: Alternative to whole-body cooling","‚Ä¢ **Deeper Hypothermia**: 32¬∞C protocols for severe HIE","‚Ä¢ **Extended Cooling**: >72 hours for refractory cases","‚Ä¢ **Combination Therapy**: Hypothermia + pharmacological agents","","üîÑ **Regenerative Medicine**:","‚Ä¢ **Stem Cell Therapy**: Mesenchymal stem cells, clinical trials","‚Ä¢ **Growth Factors**: BDNF, IGF-1, neurotrophin administration","‚Ä¢ **Gene Therapy**: Experimental approaches, future directions","‚Ä¢ **Tissue Engineering**: Neural scaffolds, bioartificial constructs","","‚ö° **Early Intervention**:","‚Ä¢ **NICU Protocols**: Developmental care, positioning, stimulation","‚Ä¢ **Family-Centered**: Parental involvement, bonding facilitation","‚Ä¢ **Therapy Services**: Physical, occupational, speech therapy","‚Ä¢ **Technology**: Assistive devices, communication aids"]},{title:"üìä Long-term Follow-up and Outcomes",points:["üë∂ **Developmental Surveillance**:","‚Ä¢ **Milestone Tracking**: Motor, cognitive, communication development","‚Ä¢ **Standardized Tools**: Bayley Scales, AIMS, PDMS assessments","‚Ä¢ **Frequency**: Regular intervals, intensified surveillance for high-risk","‚Ä¢ **Multi-disciplinary**: Pediatrics, neurology, therapy services","","üß† **Neurological Assessment**:","‚Ä¢ **Clinical Examination**: Tone, reflexes, movement patterns","‚Ä¢ **Imaging Follow-up**: Serial MRI, tract integrity assessment","‚Ä¢ **Functional Assessment**: GMFCS classification, functional outcomes","‚Ä¢ **Cognitive Testing**: IQ assessment, learning disability screening","","üìà **Quality of Life Measures**:","‚Ä¢ **Family Impact**: Stress assessment, coping mechanisms","‚Ä¢ **Social Integration**: School performance, peer relationships","‚Ä¢ **Independence**: Activities of daily living, vocational potential","‚Ä¢ **Healthcare Utilization**: Service needs, cost analysis","","üî¨ **Research and Innovation**:","‚Ä¢ **Biomarker Validation**: Predictive biomarkers, outcome correlation","‚Ä¢ **Intervention Studies**: Therapeutic efficacy, optimal timing","‚Ä¢ **Technology Development**: Assistive technologies, rehabilitation tools","‚Ä¢ **Health Economics**: Cost-effectiveness of prevention strategies"]}]}];export{e as getCPACObstetricsContent};
